Theravance Biopharma (TBPH)
Theravance Biopharma on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
1.7M
Short interest
settlement 2026-09-15
4.5
Days to cover
unchanged vs prior
34.6%
Short share of volume
2026-09-23
55
Fails to deliver
settlement 2026-09-23
Mon 9 Nov
Next earnings
estimated date
-$227K
Insider flow, 90 days
0 buys, 3 sells
As of 2026-09-25.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 September 2026, short interest in TBPH is 1,686,673 shares, down 28,274 shares over the last month. Over the last 48 readings it ranged from 1,618,508 shares (31 August 2026) to 5,592,921 shares (28 November 2025). The latest reading sits at the bottom of that range. At the reported average volume of 375K shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/tbph" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-15 | 1,686,673 | +4.2% | 375,150 | 4.50 |
| 2026-08-31 | 1,618,508 | -5.6% | 356,365 | 4.54 |
| 2026-08-14 | 1,714,947 | -58.9% | 683,553 | 2.51 |
| 2026-07-31 | 4,168,511 | -3.2% | 552,045 | 7.55 |
| 2026-07-15 | 4,306,471 | -4.4% | 811,421 | 5.31 |
| 2026-06-30 | 4,502,718 | -5.8% | 1,062,851 | 4.24 |
| 2026-06-15 | 4,778,172 | -5.1% | 356,074 | 13.42 |
| 2026-05-29 | 5,036,197 | +0.8% | 370,015 | 13.61 |
| 2026-05-15 | 4,993,657 | -3.2% | 337,670 | 14.79 |
| 2026-04-30 | 5,159,991 | -0.8% | 365,977 | 14.10 |
| 2026-04-15 | 5,204,453 | -1.1% | 416,359 | 12.50 |
| 2026-03-31 | 5,262,895 | +2.2% | 671,398 | 7.84 |
| 2026-03-13 | 5,149,873 | +8.2% | 1,266,420 | 4.07 |
| 2026-02-27 | 4,760,447 | +5.3% | 556,348 | 8.56 |
| 2026-02-13 | 4,521,474 | +2.3% | 411,810 | 10.98 |
| 2026-01-30 | 4,421,945 | -2.1% | 330,713 | 13.37 |
| 2026-01-15 | 4,516,488 | -5.9% | 426,689 | 10.58 |
| 2025-12-31 | 4,800,060 | -2.3% | 497,756 | 9.64 |
| 2025-12-15 | 4,914,934 | -12.1% | 469,553 | 10.47 |
| 2025-11-28 | 5,592,921 | +2.5% | 641,671 | 8.72 |
| 2025-11-14 | 5,457,731 | +7.4% | 593,635 | 9.19 |
| 2025-10-31 | 5,082,015 | +2.2% | 264,412 | 19.22 |
| 2025-10-15 | 4,974,009 | +0.6% | 309,067 | 16.09 |
| 2025-09-30 | 4,946,762 | -3.5% | 344,583 | 14.36 |
| 2025-09-15 | 5,125,615 | +14.9% | 566,610 | 9.05 |
| 2025-08-29 | 4,460,825 | +25.4% | 536,961 | 8.31 |
| 2025-08-15 | 3,558,770 | -13.7% | 428,001 | 8.31 |
| 2025-07-31 | 4,123,585 | +4.5% | 156,429 | 26.36 |
| 2025-07-15 | 3,945,366 | -5.2% | 159,627 | 24.72 |
| 2025-06-30 | 4,162,817 | +4.7% | 275,881 | 15.09 |
| 2025-06-13 | 3,977,181 | +4.9% | 452,535 | 8.79 |
| 2025-05-30 | 3,790,310 | -5.9% | 220,552 | 17.19 |
| 2025-05-15 | 4,029,761 | +3.6% | 350,890 | 11.48 |
| 2025-04-30 | 3,889,972 | +8.1% | 216,513 | 17.97 |
| 2025-04-15 | 3,598,867 | +0.9% | 240,800 | 14.95 |
| 2025-03-31 | 3,566,516 | -2.6% | 178,083 | 20.03 |
| 2025-03-14 | 3,661,778 | -1.8% | 243,667 | 15.03 |
| 2025-02-28 | 3,728,702 | -5.3% | 399,460 | 9.33 |
| 2025-02-14 | 3,937,371 | -1.8% | 161,399 | 24.40 |
| 2025-01-31 | 4,010,829 | +1.3% | 238,696 | 16.80 |
| 2025-01-15 | 3,960,631 | +1.3% | 159,867 | 24.77 |
| 2024-12-31 | 3,911,157 | -4.0% | 171,534 | 22.80 |
| 2024-12-13 | 4,072,705 | -5.7% | 201,693 | 20.19 |
| 2024-11-29 | 4,317,167 | -11.0% | 245,697 | 17.57 |
| 2024-11-15 | 4,852,704 | -1.4% | 206,101 | 23.55 |
| 2024-10-31 | 4,922,641 | -2.3% | 119,854 | 41.07 |
| 2024-10-15 | 5,036,784 | -3.8% | 186,124 | 27.06 |
| 2024-09-30 | 5,237,799 | -2.2% | 220,636 | 23.74 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 September 2026, the short share of TBPH volume is 34.6%, down 21.4 points over the last five sessions. Over the last 30 readings it ranged from 20.7% (22 September 2026) to 72.3% (9 September 2026). The latest reading is 11.7 points below the 30-session average of 46.3%, on 562K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-23 | 195K | 562K | 34.6% | 5,557 |
| 2026-09-22 | 240K | 1.2M | 20.7% | 4 |
| 2026-09-21 | 58K | 184K | 31.7% | 0 |
| 2026-09-18 | 36K | 101K | 35.6% | 0 |
| 2026-09-17 | 53K | 104K | 51.2% | 0 |
| 2026-09-16 | 72K | 129K | 56.0% | 0 |
| 2026-09-15 | 89K | 150K | 59.2% | 0 |
| 2026-09-14 | 31K | 68K | 46.0% | 0 |
| 2026-09-11 | 45K | 86K | 53.0% | 3,100 |
| 2026-09-10 | 46K | 71K | 64.5% | 0 |
| 2026-09-09 | 36K | 50K | 72.3% | 0 |
| 2026-09-08 | 27K | 55K | 49.6% | 0 |
| 2026-09-04 | 20K | 49K | 41.4% | 0 |
| 2026-09-03 | 25K | 68K | 37.0% | 333 |
| 2026-09-02 | 146K | 254K | 57.4% | 1,800 |
| 2026-09-01 | 82K | 184K | 44.5% | 0 |
| 2026-08-31 | 29K | 76K | 38.4% | 100 |
| 2026-08-28 | 69K | 135K | 51.3% | 88 |
| 2026-08-27 | 65K | 152K | 42.9% | 0 |
| 2026-08-26 | 29K | 86K | 33.6% | 0 |
| 2026-08-25 | 47K | 115K | 41.1% | 0 |
| 2026-08-24 | 43K | 120K | 35.5% | 0 |
| 2026-08-21 | 167K | 245K | 68.0% | 97,238 |
| 2026-08-20 | 33K | 69K | 48.4% | 0 |
| 2026-08-19 | 32K | 76K | 42.5% | 0 |
| 2026-08-18 | 46K | 80K | 57.9% | 0 |
| 2026-08-17 | 50K | 101K | 49.3% | 25 |
| 2026-08-14 | 70K | 128K | 54.7% | 0 |
| 2026-08-13 | 50K | 128K | 39.2% | 0 |
| 2026-08-12 | 59K | 184K | 31.8% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 23 September 2026, the fails-to-deliver balance in TBPH is 55 shares, down 1,315 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (27 August 2026) to 39,518 shares (26 March 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-23 | 55 | $17.03 | $937 |
| 2026-09-21 | 1,370 | $17.02 | $23K |
| 2026-09-10 | 10 | $17.06 | $171 |
| 2026-08-27 | 3 | $17.03 | $51 |
| 2026-08-20 | 12 | $16.99 | $204 |
| 2026-08-05 | 1,896 | $16.88 | $32K |
| 2026-08-04 | 200 | $16.87 | $3K |
| 2026-08-03 | 587 | $16.86 | $10K |
| 2026-07-20 | 20 | $16.93 | $339 |
| 2026-07-14 | 28,180 | $16.90 | $476K |
| 2026-06-17 | 19 | $16.69 | $317 |
| 2026-06-09 | 983 | $16.29 | $16K |
| 2026-06-05 | 7,249 | $16.37 | $119K |
| 2026-05-26 | 27 | $16.37 | $442 |
| 2026-05-13 | 21,413 | $16.48 | $353K |
| 2026-04-16 | 116 | $16.64 | $2K |
| 2026-04-09 | 58 | $16.60 | $963 |
| 2026-03-26 | 39,518 | $15.29 | $604K |
| 2026-03-25 | 22,321 | $14.90 | $333K |
| 2026-03-23 | 11 | $14.33 | $158 |
| 2026-03-05 | 1,105 | $13.67 | $15K |
| 2026-03-04 | 43 | $13.96 | $600 |
| 2026-02-04 | 980 | $19.99 | $20K |
| 2026-02-02 | 22 | $18.94 | $417 |
| 2026-01-26 | 53 | $20.24 | $1K |
| 2026-01-22 | 439 | $20.37 | $9K |
| 2026-01-21 | 741 | $20.42 | $15K |
| 2026-01-14 | 5 | $20.33 | $102 |
| 2026-01-09 | 262 | $19.02 | $5K |
| 2026-01-05 | 571 | $18.15 | $10K |
Insider trades
SEC Form 4, newest first. JSONInsiders at TBPH reported 3 open-market sells worth $227K in the last 90 days and no open-market buys. Latest filing: Weiss Asset Management LP (Former 10% Owner) on 2026-09-23.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Weiss Asset Management LP | Former 10% Owner | Other transaction | 7.5M | $17.00 | $126.8M | 0 |
| 2026-09-23 | Smaldone Alsup Laurie | Director | Returned to company | 6K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Smaldone Alsup Laurie | Director | Returned to company | 75K | price not stated in the filing | not stated | 6K |
| 2026-09-23 | GRAY SUSANNAH | Director | Returned to company | 6K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | GRAY SUSANNAH | Director | Returned to company | 42K | price not stated in the filing | not stated | 6K |
| 2026-09-23 | MITCHELL DEAN J | Director | Returned to company | 6K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | MITCHELL DEAN J | Director | Returned to company | 91K | price not stated in the filing | not stated | 6K |
| 2026-09-23 | O'Connor Donal | Director | Returned to company | 6K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | O'Connor Donal | Director | Returned to company | 74K | price not stated in the filing | not stated | 6K |
| 2026-09-23 | PAKIANATHAN DEEPIKA | Director | Returned to company | 6K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | PAKIANATHAN DEEPIKA | Director | Returned to company | 58K | price not stated in the filing | not stated | 6K |
| 2026-09-23 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Returned to company | 89K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Returned to company | 124K | price not stated in the filing | not stated | 89K |
| 2026-09-23 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Returned to company | 23K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Returned to company | 108K | price not stated in the filing | not stated | 23K |
| 2026-09-23 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Returned to company | 224K | price not stated in the filing | not stated | 131K |
| 2026-09-23 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Returned to company | 97K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Returned to company | 93K | price not stated in the filing | not stated | 97K |
| 2026-09-23 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Returned to company | 23K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Returned to company | 108K | price not stated in the filing | not stated | 23K |
| 2026-09-23 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Returned to company | 205K | price not stated in the filing | not stated | 132K |
| 2026-09-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Returned to company | 93K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Returned to company | 23K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Returned to company | 77K | price not stated in the filing | not stated | 0 |
| 2026-09-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Returned to company | 152K | price not stated in the filing | not stated | 77K |
| 2026-09-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Returned to company | 1.4M | price not stated in the filing | not stated | 229K |
| 2026-09-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 7K | $17.03 | $113K | 213K |
| 2026-09-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3K | $17.03 | $57K | 220K |
| 2026-09-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3K | $17.03 | $57K | 223K |
| 2026-08-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 20K | $16.95 | $340K | 1.6M |
| 2026-08-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 8K | $16.95 | $137K | 337K |
| 2026-08-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 6K | $16.95 | $106K | 190K |
| 2026-08-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 8K | $16.95 | $135K | 355K |
| 2026-08-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 6K | $16.95 | $96K | 227K |
| 2026-07-07 | Samaha Eli | 10% owner | Sell | 6K | $17.17 | $96K | 9.2M |
| 2026-07-06 | Samaha Eli | 10% owner | Sell | 1K | $17.04 | $24K | 9.2M |
| 2026-07-01 | Samaha Eli | 10% owner | Sell | 38K | $17.00 | $643K | 9.2M |
| 2026-06-30 | Samaha Eli | 10% owner | Sell | 25K | $17.13 | $429K | 9.2M |
| 2026-06-29 | Samaha Eli | 10% owner | Sell | 274K | $17.23 | $4.7M | 9.2M |
| 2026-06-19 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Grant | 19K | $0.00 | $0 | 196K |
| 2026-06-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 7K | $16.39 | $109K | 232K |
| 2026-06-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3K | $16.38 | $55K | 239K |
| 2026-06-15 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3K | $16.39 | $55K | 242K |
| 2026-06-12 | PAKIANATHAN DEEPIKA | Director | Grant | 6K | $0.00 | $0 | 64K |
| 2026-06-12 | O'Connor Donal | Director | Grant | 6K | $0.00 | $0 | 80K |
| 2026-06-12 | MITCHELL DEAN J | Director | Grant | 6K | $0.00 | $0 | 97K |
| 2026-06-12 | GRAY SUSANNAH | Director | Grant | 6K | $0.00 | $0 | 48K |
| 2026-06-12 | Smaldone Alsup Laurie | Director | Grant | 6K | $0.00 | $0 | 81K |
| 2026-05-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 20K | $16.55 | $332K | 1.6M |
| 2026-05-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 9K | $16.55 | $143K | 345K |
| 2026-05-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 7K | $16.55 | $113K | 177K |
| 2026-05-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 9K | $16.55 | $146K | 363K |
| 2026-05-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 6K | $16.55 | $94K | 246K |
| 2026-04-01 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Grant | 75K | $0.00 | $0 | 1.7M |
| 2026-04-01 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Grant | 38K | $0.00 | $0 | 354K |
| 2026-04-01 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Grant | 38K | $0.00 | $0 | 372K |
| 2026-04-01 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Grant | 19K | $0.00 | $0 | 251K |
| 2026-03-16 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 8K | $13.92 | $108K | 233K |
| 2026-03-16 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 16K | $14.00 | $217K | 240K |
| 2026-03-16 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 8K | $13.92 | $108K | 256K |
| 2026-02-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 75K | $19.66 | $1.5M | 1.6M |
| 2026-02-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 21K | $19.66 | $406K | 316K |
| 2026-02-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 17K | $19.66 | $331K | 184K |
| 2026-02-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 21K | $19.66 | $410K | 334K |
| 2026-02-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 14K | $19.66 | $274K | 264K |
| 2025-12-03 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 16K | $18.75 | $291K | 278K |
| 2025-12-03 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 8K | $18.75 | $146K | 293K |
| 2025-12-03 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 8K | $18.75 | $146K | 301K |
| 2025-11-26 | BROSHY ERAN | Director | Sell | 16K | $20.00 | $310K | 45K |
| 2025-11-26 | BROSHY ERAN | Director | Sell | 14K | $20.00 | $280K | 60K |
| 2025-11-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 57K | $17.90 | $1.0M | 1.7M |
| 2025-11-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 19K | $17.90 | $333K | 337K |
| 2025-11-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 7K | $17.90 | $125K | 201K |
| 2025-11-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 19K | $17.90 | $341K | 355K |
| 2025-11-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 9K | $17.90 | $162K | 309K |
| 2025-11-19 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Gift | 10K | $0.00 | $0 | 23K |
| 2025-11-19 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Gift | 10K | $0.00 | $0 | 1.7M |
| 2025-11-11 | BROSHY ERAN | Director | Sell | 16K | $18.50 | $287K | 76K |
| 2025-11-11 | BROSHY ERAN | Director | Sell | 14K | $18.50 | $259K | 60K |
| 2025-11-11 | BROSHY ERAN | Director | Sell | 14K | $18.50 | $259K | 46K |
| 2025-11-11 | BROSHY ERAN | Director | Sell | 16K | $17.00 | $264K | 46K |
| 2025-11-11 | BROSHY ERAN | Director | Sell | 30K | $18.50 | $546K | 62K |
| 2025-08-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 15K | $13.39 | $206K | 1.7M |
| 2025-08-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 9K | $13.39 | $125K | 355K |
| 2025-08-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 7K | $13.39 | $94K | 208K |
| 2025-08-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 10K | $13.39 | $131K | 374K |
| 2025-08-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 9K | $13.39 | $122K | 318K |
| 2025-07-14 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 4K | $11.39 | $46K | 327K |
| 2025-07-14 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 5K | $11.39 | $61K | 331K |
| 2025-07-14 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 682 | $11.39 | $8K | 336K |
| 2025-06-23 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Gift | 20K | $0.00 | $0 | 1.7M |
| 2025-06-13 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Gift | 10K | $0.00 | $0 | 14K |
| 2025-06-13 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Gift | 10K | $0.00 | $0 | 1.8M |
| 2025-06-02 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 24K | $11.00 | $264K | 337K |
| 2025-05-20 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Tax withholding | 10K | $9.45 | $92K | 215K |
| 2025-05-20 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Tax withholding | 9K | $9.45 | $86K | 361K |
| 2025-05-20 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Tax withholding | 10K | $9.45 | $92K | 384K |
| 2025-05-20 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Tax withholding | 9K | $9.45 | $88K | 365K |
| 2025-05-20 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Tax withholding | 15K | $9.45 | $145K | 1.8M |
| 2025-05-19 | Smaldone Alsup Laurie | Director | Grant | 11K | $0.00 | $0 | 75K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON6 Form 144 notices on file for TBPH worth $2.9M at the prices reported; 1 in the last 90 days worth $227K. Latest: RHONDA FARNUM filed on 2026-09-15 to sell 13,314 shares ($227K) from 2026-09-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-15 | RHONDA FARNUMOfficer | 13K | $227K | 0.026% | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | RHONDA FARNUMOfficer | 13K | $218K | 0.026% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-16 | RHONDA FARNUMOfficer | 31K | $434K | 0.061% | 2026-03-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-03 | RHONDA FARNUMOfficer | 31K | $583K | 0.061% | 2025-12-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-26 | ERAN BROSHYDirector | 30K | $590K | 0.058% | 2025-11-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | ERAN BROSHYDirector | 45K | $809K | 0.089% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON7 holders report 5% or more of TBPH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Madison Avenue GP, LLC at 17.7% of the class (9,212,252 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-09-25 | 13D/Ano. 4 | Andrew M. Weissparent holding company, individual | 0 | 0.0% | 2026-09-23 |
| 2026-09-25 | 13D/Ano. 4 | BIP GP LLCparent holding company, other entity | 0 | 0.0% | 2026-09-23 |
| 2026-09-25 | 13D/Ano. 4 | WAM GP LLCparent holding company, other entity | 0 | 0.0% | 2026-09-23 |
| 2026-09-25 | 13D/Ano. 4 | Weiss Asset Management LPinvestment adviser, partnership | 0 | 0.0% | 2026-09-23 |
| 2026-08-14 | 13G/Ano. 3 | Newtyn Management, LLCinvestment adviser | 3.4M | 6.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 3 | Newtyn TE Partners, LPpartnership | 2.2M | 4.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | Madison Avenue GP, LLCother entity | 9.2M | 17.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | Caraway Jackson Investments LLCother entity | 9.2M | 17.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | Eli Samahaindividual | 9.2M | 17.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | Madison Avenue International LPother entity | 9.2M | 17.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | Madison Avenue Partners, LPother entity | 9.2M | 17.7% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | EMAI Management, LLCother entity | 9.2M | 17.7% | 2026-06-30 |
13F holders
Tracked managers holding TBPH at their latest 13F. JSON6 of the 30 tracked managers held TBPH at their latest 13F, $55.0M in total at quarter-end prices. Two Sigma Investments is the largest at $20.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 1.2M | $20.8M | 0.02% | -33K |
| D. E. Shaw & Co. | 2026-06-30 | 1.2M | $20.2M | 0.01% | +231K |
| Citadel Advisors | 2026-06-30 | 507K | $8.6M | 0.00% | +421K |
| Renaissance Technologies | 2026-06-30 | 154K | $2.6M | 0.00% | +26K |
| Millennium Management | 2026-06-30 | 115K | $2.0M | 0.00% | new |
| AQR Capital Management | 2026-06-30 | 48K | $813K | 0.00% | +20K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Theravance Biopharma in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Theravance Biopharma (TBPH), SEC CIK 1583107, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-09-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-23.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-25.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-07.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-23.JSON and CSV
- Company record
- EDGAR filing index for CIK 1583107Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of TBPH is sold short?
1,686,673 shares were held short at the 2026-09-15 settlement, 4.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TBPH's daily short volume?
On 2026-09-23, 194,650 of the 562,276 TBPH shares reported to FINRA were sold short, 34.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TBPH have fails to deliver?
The SEC's latest file shows 55 TBPH shares failed to deliver at settlement 2026-09-23. Fails are reported per settlement date and published twice a month with a lag.
Are TBPH insiders buying or selling?
Insiders at TBPH reported 3 open-market sells worth $227K in the last 90 days and no open-market buys. Latest filing: Weiss Asset Management LP (Former 10% Owner) on 2026-09-23.
Have TBPH insiders filed to sell?
6 Form 144 notices on file for TBPH worth $2.9M at the prices reported; 1 in the last 90 days worth $227K. Latest: RHONDA FARNUM filed on 2026-09-15 to sell 13,314 shares ($227K) from 2026-09-15.
Who owns 5% or more of TBPH?
7 holders report 5% or more of TBPH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Madison Avenue GP, LLC at 17.7% of the class (9,212,252 shares), filed 2026-08-14 for an event on 2026-06-30.
Which tracked 13F managers own TBPH?
6 of the 30 tracked 13F managers held TBPH shares at their latest filing, $55.0M in all. The largest: Two Sigma Investments (1.2M shares, $20.8M), D. E. Shaw & Co. (1.2M shares, $20.2M), Ken Griffin's Citadel Advisors (507K shares, $8.6M), Renaissance Technologies (154K shares, $2.6M), Izzy Englander's Millennium Management (115K shares, $2.0M), Cliff Asness's AQR Capital Management (48K shares, $813K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.